TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Sergio Serrano-Villar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.